Search - tctmd.com

Displaying 201 - 220 of 403

Sort: Relevancy | Date

News Conference News ESC 2022

EchoNet AI Algorithm Beats Sonographers for Estimating LV Function

Shelley Wood

August 27, 2022

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Daily News

‘Stunning’ Lack of Data on CV Issues in Pregnant Women With COVID-19

L.A. McKeown

August 10, 2022

News Daily News

Early LV Recovery After TAVI Points to Better 5-Year Survival

Yael L. Maxwell

August 01, 2022

News Daily News

Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19

Michael O'Riordan

July 20, 2022

News Features

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

Shelley Wood

July 07, 2022

News Daily News

Grieving a Loved One Increases Mortality Risk in HF Patients

L.A. McKeown

July 06, 2022

News Opinion Off Script

To Save a Dying Mother

Kathryn J. Lindley, MD

June 28, 2022

News Daily News

Many Hurdles to Clear Before Cardiac Xenotransplantation Takes Off

Yael L. Maxwell

June 16, 2022

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

News Conference News ESC Heart Failure 2022

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

Todd Neale

May 31, 2022

News Conference News ESC Heart Failure 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

Shelley Wood

May 25, 2022

News Conference News EuroPCR 2022

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

Michael O'Riordan

May 20, 2022

News Conference News EuroPCR 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

Michael O'Riordan

May 19, 2022

News Conference News HRS 2022

Evidence Grows for Conduction-System Pacing as an Alternative to CRT

Todd Neale

May 05, 2022

News Daily News

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Michael O'Riordan

April 29, 2022

Presentation ARCH 2022

Left Ventricular Remodeling & Device Therapy in HF

Presenter: Justin Vader

April 23, 2022

News Conference News ACC 2022

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

Shelley Wood

April 03, 2022

News Daily News

Prognosis of Myocarditis Following COVID-19 Vaccination ‘Favorable’

Michael O'Riordan

March 28, 2022

Advertisement

EchoNet AI Algorithm Beats Sonographers for Estimating LV Function

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

‘Stunning’ Lack of Data on CV Issues in Pregnant Women With COVID-19

Early LV Recovery After TAVI Points to Better 5-Year Survival

Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

Grieving a Loved One Increases Mortality Risk in HF Patients

To Save a Dying Mother

Many Hurdles to Clear Before Cardiac Xenotransplantation Takes Off

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

Evidence Grows for Conduction-System Pacing as an Alternative to CRT

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Left Ventricular Remodeling & Device Therapy in HF

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

Prognosis of Myocarditis Following COVID-19 Vaccination ‘Favorable’

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content